US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Tvardi Therapeutics Inc

1.15

-0.0900-7.26%

Post-market: 1.170.0200+1.74%19:30 EDT

Volume:313.81K

Turnover:370.17K

Market Cap:15.34M

PE:-0.41

High:1.28

Open:1.25

Low:1.13

Close:1.24

52wk High:43.65

52wk Low:0.9300

Shares:13.34M

Float Shares:5.67M

Volume Ratio:0.86

T/O Rate:5.53%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.7737

EPS(LYR):-3.2600

ROE:-126.19%

ROA:-55.51%

PB:1.83

PE(LYR):-0.35

Loading ...

Overview Company News Filings

Tvardi Publishes New Preclinical Ulcerative Colitis Data for STAT3 Inhibitor TTI-101 in Int J Mol Sci

Tvardi Therapeutics, - Phase 1 Study of Tti-109 Shows Predictable Pharmacokinetics and Favorable Gi Tolerability

THOMSON REUTERS

Analysts Conflicted on These Healthcare Names: Veeva Systems (VEEV), Mereo Biopharma Group Plc (MREO) and Tvardi Therapeutics (TVRD)

Tvardi Therapeutics to Attend Wells Fargo, Cantor Global Healthcare Investor Conferences

Tvardi Therapeutics to Participate in Upcoming Investor Events

Tvardi Therapeutics (TVRD) Receives a Hold from Cantor Fitzgerald

Analysts Are Bullish on These Healthcare Stocks: Tvardi Therapeutics (TVRD), GE Healthcare Technologies Inc (GEHC)

Tvardi Therapeutics (TVRD) Gets a Sell from Barclays

Tvardi Therapeutics Posts KOL Webinar Deck on TTI-109 Potential in Ulcerative Colitis

Tvardi Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Tvardi Q2 FY26 Net Loss Turns to USD 6.5 Million

Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update

THOMSON REUTERS

Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million VS. Ibes Estimate USD -6.54 Million

THOMSON REUTERS

Tvardi Therapeutics to Host KOL Webinar on TTI-109 Potential in Ulcerative Colitis

Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE), Stereotaxis (STXS) and Tvardi Therapeutics (TVRD)

Tvardi Therapeutics, Inc. Expected to Post a Loss of 70 Cents a Share - Earnings Preview

Tvardi Therapeutics (TVRD) Gets a Sell from Barclays

Analysts’ Top Healthcare Picks: Tvardi Therapeutics (TVRD), Disc Medicine (IRON)

Tvardi Therapeutics Plans 2027 Mid-to-late Stage Ulcerative Colitis Trial for STAT3 Inhibitor Tti-109

Tvardi Therapeutics - Increases At-the-market Offering Program to $9.69 Mln in Shares - SEC Filing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/TVRD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TVRD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","market":"US","secType":"STK","nameCN":"Tvardi Therapeutics Inc","latestPrice":1.15,"timestamp":1790971200000,"preClose":1.24,"halted":0,"volume":313810,"hourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.15,"latestTime":"19:30 EDT","volume":1474,"amount":1705.18,"timestamp":1790983803092,"change":0.02,"changeRate":0.017391,"amplitude":0.017391},"delay":0,"changeRate":-0.07258064516129038,"floatShares":5671300,"shares":13338900,"eps":-2.773725,"marketStatus":"Market Closed","change":-0.09,"latestTime":"10-02 16:00:00 EDT","open":1.25,"high":1.277,"low":1.13,"amount":370171.43709699996,"amplitude":0.118548,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.773725,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":1.24,"preHourTrading":{"tag":"盘前","latestPrice":1.24,"preClose":1.24,"latestTime":"09:28 EDT","volume":85,"amount":104.638604,"timestamp":1790947688717,"change":0,"changeRate":0,"amplitude":0.011371},"postHourTrading":{"tag":"盘后","latestPrice":1.17,"preClose":1.15,"latestTime":"19:30 EDT","volume":1474,"amount":1705.18,"timestamp":1790983803092,"change":0.02,"changeRate":0.017391,"amplitude":0.017391},"volumeRatio":0.857836,"impliedVol":1.6459,"impliedVolPercentile":0.4861},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVRD\",,,,,undefined,":{"symbol":"TVRD","floatShares":5671300,"roa":"-55.51%","roe":"-126.19%","lyrEps":-3.259999,"volumeRatio":0.857836,"shares":13338900,"dividePrice":0,"high":1.277,"amplitude":0.118548,"preClose":1.24,"low":1.13,"week52Low":0.93,"pbRate":"1.83","week52High":43.65,"institutionHeld":0,"latestPrice":1.15,"eps":-2.773725,"divideRate":0,"volume":313810,"delay":0,"ttmEps":-2.773725,"open":1.25,"prevYearClose":4.3,"prevWeekClose":1.27,"prevMonthClose":1.25,"prevQuarterClose":1.25,"fiveDayClose":1.27,"twentyDayClose":1.85,"sixtyDayClose":3.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVRD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-14","symbol":"TVRD","fiscalQuarterEnding":"2026/06","expectedEps":-0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786680000000,"reportTimeType":"pre","actualEps":-0.69},{"market":"US","date":"2026-05-08","symbol":"TVRD","fiscalQuarterEnding":"2026/03","expectedEps":-0.65,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2026-03-31","symbol":"TVRD","fiscalQuarterEnding":"2025/12","expectedEps":-0.55,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":-0.78},{"market":"US","date":"2025-11-13","symbol":"TVRD","fiscalQuarterEnding":"2025/09","expectedEps":-0.83,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.59},{"market":"US","date":"2025-08-14","symbol":"TVRD","fiscalQuarterEnding":"2025/06","expectedEps":-0.51,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":1}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVRD\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVRD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.5556,"hold":0.1111,"sell":0.1111,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5556,"analysts":9,"updateTime":1788926400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TVRD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TVRD","date":"2026-10-01","current":-0.414605,"percent":0.996622,"low":-17.054928,"twenty":-2.603079,"median":-1.637898,"eighty":-1.425031,"high":-0.542504,"avg":-3.424162,"sd":4.185157,"marketCap":16673678},"quantilePoints":[{"date":"2025-08-01","current":-6.984237,"twenty":-7.018674,"median":-6.984237,"eighty":-6.867475,"marketCap":242869870},{"date":"2025-08-08","current":-6.220168,"twenty":-7.05634,"median":-6.986928,"eighty":-6.651705,"marketCap":216300131},{"date":"2025-08-15","current":-6.400424,"twenty":-7.003609,"median":-6.690985,"eighty":-6.397734,"marketCap":222568344},{"date":"2025-08-22","current":-10.573024,"twenty":-9.576632,"median":-6.986928,"eighty":-6.42948,"marketCap":249861702},{"date":"2025-08-29","current":-12.013447,"twenty":-10.759129,"median":-7.048807,"eighty":-6.480866,"marketCap":283901784},{"date":"2025-09-05","current":-12.078921,"twenty":-11.588463,"median":-7.134899,"eighty":-6.493511,"marketCap":285449060},{"date":"2025-09-12","current":-14.047103,"twenty":-11.928926,"median":-9.803211,"eighty":-6.612426,"marketCap":331961128},{"date":"2025-09-19","current":-15.372451,"twenty":-12.457478,"median":-10.666275,"eighty":-6.823352,"marketCap":363281754},{"date":"2025-09-26","current":-14.606606,"twenty":-13.432046,"median":-11.499578,"eighty":-6.955181,"marketCap":345183308},{"date":"2025-10-03","current":-14.82882,"twenty":-14.620891,"median":-11.737664,"eighty":-6.987466,"marketCap":350434671},{"date":"2025-10-10","current":-17.054928,"twenty":-14.850248,"median":-11.943013,"eighty":-6.991233,"marketCap":403042070},{"date":"2025-10-17","current":-2.571334,"twenty":-14.850248,"median":-11.769409,"eighty":-6.823352,"marketCap":60765765},{"date":"2025-10-24","current":-2.047544,"twenty":-14.833582,"median":-11.58886,"eighty":-6.422216,"marketCap":48387554},{"date":"2025-10-31","current":-1.849138,"twenty":-14.74787,"median":-11.130543,"eighty":-4.843171,"marketCap":43698837},{"date":"2025-11-07","current":-1.563435,"twenty":-14.662953,"median":-10.195062,"eighty":-2.595143,"marketCap":36947086},{"date":"2025-11-14","current":-1.631573,"twenty":-14.620891,"median":-9.523459,"eighty":-2.06421,"marketCap":38557323},{"date":"2025-11-21","current":-1.515552,"twenty":-14.489944,"median":-7.06764,"eighty":-1.887232,"marketCap":35836734},{"date":"2025-11-28","current":-1.634574,"twenty":-14.266143,"median":-6.990963,"eighty":-1.811838,"marketCap":38651137},{"date":"2025-12-05","current":-1.658378,"twenty":-13.805842,"median":-6.911597,"eighty":-1.667399,"marketCap":39214017},{"date":"2025-12-12","current":-1.781368,"twenty":-13.436014,"median":-6.493242,"eighty":-1.662637,"marketCap":42122234},{"date":"2025-12-19","current":-1.543324,"twenty":-13.412999,"median":-6.400424,"eighty":-1.660082,"marketCap":36493428},{"date":"2025-12-26","current":-1.5949,"twenty":-13.32332,"median":-6.349307,"eighty":-1.639335,"marketCap":37713002},{"date":"2026-01-02","current":-1.705987,"twenty":-13.031267,"median":-2.777676,"eighty":-1.642509,"marketCap":40339779},{"date":"2026-01-09","current":-1.678216,"twenty":-12.62652,"median":-2.62292,"eighty":-1.634574,"marketCap":39683085},{"date":"2026-01-16","current":-1.789303,"twenty":-12.344784,"median":-2.448323,"eighty":-1.634574,"marketCap":42309861},{"date":"2026-01-23","current":-1.91626,"twenty":-12.181298,"median":-2.07532,"eighty":-1.634574,"marketCap":45311891},{"date":"2026-01-30","current":-1.547291,"twenty":-12.091222,"median":-1.95231,"eighty":-1.634574,"marketCap":36587241},{"date":"2026-02-06","current":-1.408431,"twenty":-12.026542,"median":-1.896756,"eighty":-1.617117,"marketCap":33303771},{"date":"2026-02-13","current":-1.475877,"twenty":-11.900753,"median":-1.8627,"eighty":-1.598129,"marketCap":34898599},{"date":"2026-02-20","current":-1.424301,"twenty":-11.810677,"median":-1.847154,"eighty":-1.590139,"marketCap":33679024},{"date":"2026-02-27","current":-1.606802,"twenty":-11.750362,"median":-1.836912,"eighty":-1.577443,"marketCap":37994443},{"date":"2026-03-06","current":-1.5949,"twenty":-11.649572,"median":-1.807157,"eighty":-1.573476,"marketCap":37713002},{"date":"2026-03-13","current":-1.458024,"twenty":-11.588463,"median":-1.789617,"eighty":-1.565651,"marketCap":34476439},{"date":"2026-03-20","current":-1.460008,"twenty":-11.482118,"median":-1.781368,"eighty":-1.559193,"marketCap":34523345},{"date":"2026-03-27","current":-1.321148,"twenty":-11.243237,"median":-1.741999,"eighty":-1.553639,"marketCap":31239875},{"date":"2026-04-02","current":-1.545187,"twenty":-10.944836,"median":-1.71789,"eighty":-1.546029,"marketCap":28144032},{"date":"2026-04-10","current":-1.524584,"twenty":-10.628975,"median":-1.704004,"eighty":-1.543324,"marketCap":27768778},{"date":"2026-04-17","current":-1.6585,"twenty":-10.270654,"median":-1.682478,"eighty":-1.543324,"marketCap":30207927},{"date":"2026-04-24","current":-1.550337,"twenty":-9.805989,"median":-1.678216,"eighty":-1.544069,"marketCap":28237845},{"date":"2026-05-01","current":-1.622446,"twenty":-9.682977,"median":-1.674248,"eighty":-1.546029,"marketCap":29551233},{"date":"2026-05-08","current":-2.168412,"twenty":-8.568035,"median":-1.676379,"eighty":-1.548509,"marketCap":39495458},{"date":"2026-05-15","current":-2.406252,"twenty":-7.115528,"median":-1.682478,"eighty":-1.550705,"marketCap":37150122},{"date":"2026-05-22","current":-2.181425,"twenty":-7.071406,"median":-1.707971,"eighty":-1.552845,"marketCap":33679024},{"date":"2026-05-29","current":-2.120661,"twenty":-7.037507,"median":-1.719873,"eighty":-1.555226,"marketCap":32740890},{"date":"2026-06-05","current":-1.871529,"twenty":-6.991771,"median":-1.746061,"eighty":-1.555226,"marketCap":28894539},{"date":"2026-06-12","current":-1.646703,"twenty":-6.988542,"median":-1.736886,"eighty":-1.555278,"marketCap":25423442},{"date":"2026-06-18","current":-1.56771,"twenty":-6.984237,"median":-1.719873,"eighty":-1.555488,"marketCap":24203867},{"date":"2026-06-26","current":-1.434029,"twenty":-6.911597,"median":-1.705987,"eighty":-1.555226,"marketCap":22139971},{"date":"2026-07-02","current":-1.184897,"twenty":-6.735107,"median":-1.689237,"eighty":-1.549728,"marketCap":18293620},{"date":"2026-07-10","current":-2.30903,"twenty":-6.533867,"median":-1.695629,"eighty":-1.54687,"marketCap":35649107},{"date":"2026-07-17","current":-1.871529,"twenty":-6.492435,"median":-1.709955,"eighty":-1.549728,"marketCap":28894539},{"date":"2026-07-24","current":-1.555557,"twenty":-6.447775,"median":-1.713922,"eighty":-1.551074,"marketCap":24016240},{"date":"2026-07-31","current":-1.276043,"twenty":-6.414952,"median":-1.704004,"eighty":-1.544474,"marketCap":19700822},{"date":"2026-08-07","current":-1.124133,"twenty":-6.392353,"median":-1.682478,"eighty":-1.541737,"marketCap":17355486},{"date":"2026-08-14","current":-1.075522,"twenty":-6.364373,"median":-1.67765,"eighty":-1.526306,"marketCap":16604978},{"date":"2026-08-21","current":-0.658706,"twenty":-6.271824,"median":-1.674248,"eighty":-1.509204,"marketCap":17167859},{"date":"2026-08-28","current":-0.921233,"twenty":-4.310985,"median":-1.663144,"eighty":-1.491321,"marketCap":24010097},{"date":"2026-09-04","current":-0.946823,"twenty":-2.881884,"median":-1.6585,"eighty":-1.478258,"marketCap":24677044},{"date":"2026-09-11","current":-0.939146,"twenty":-2.728471,"median":-1.658378,"eighty":-1.472643,"marketCap":24476960},{"date":"2026-09-18","current":-0.82911,"twenty":-2.646728,"median":-1.653288,"eighty":-1.452073,"marketCap":21609087},{"date":"2026-09-25","current":-0.542504,"twenty":-2.6253,"median":-1.642509,"eighty":-1.430573,"marketCap":14139279},{"date":"2026-10-01","current":-0.639745,"twenty":-2.603079,"median":-1.637898,"eighty":-1.425031,"marketCap":16673678}],"updateTime":1791002328670},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TVRD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669446058","title":"Tvardi Publishes New Preclinical Ulcerative Colitis Data for STAT3 Inhibitor TTI-101 in Int J Mol Sci","url":"https://stock-news.laohu8.com/highlight/detail?id=2669446058","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669446058?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251238,"startTime":"0","endTime":"0","summary":"Tvardi publishes new preclinical ulcerative colitis data for STAT3 inhibitor TTI-101 in Int J Mol SciTvardi Therapeutics disclosed newly published preclinical ulcerative colitis data supporting its ST","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nNDL81GJ4D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00B3QW5Z07.USD","NDAQ","TVRD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU0314104364.USD","SG9999014005.SGD","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014039.USD","IE00BQXX3D17.EUR","BK4585","BK4588","IE00B64PRP62.GBP","IE00BQXX3F31.USD","SG9999014021.USD","IE00BKPKM429.USD","BK4007","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BQXX3C00.GBP","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669460318","title":"Tvardi Therapeutics, - Phase 1 Study of Tti-109 Shows Predictable Pharmacokinetics and Favorable Gi Tolerability","url":"https://stock-news.laohu8.com/highlight/detail?id=2669460318","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669460318?lang=en_us&edition=fundamental","pubTime":"2026-09-24 20:00","pubTimestamp":1790251231,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nFWN45G0QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TVRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667455621","title":"Analysts Conflicted on These Healthcare Names: Veeva Systems (VEEV), Mereo Biopharma Group Plc (MREO) and Tvardi Therapeutics (TVRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2667455621","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667455621?lang=en_us&edition=fundamental","pubTime":"2026-09-16 02:50","pubTimestamp":1789498210,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Veeva Systems (VEEV), Mereo Biopharma Group Plc (M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-veeva-systems-veev-mereo-biopharma-group-plc-mreo-and-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-veeva-systems-veev-mereo-biopharma-group-plc-mreo-and-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4581","BK4534","MREO","BK4504","LGHT","BK4613","LU1989764748.USD","EKG","LU0266013472.USD","LU1989764664.SGD","BK4588","LU0128526141.USD","TVRD","LU0170899867.USD","HCSG","BK4007","BK4167","XLV","LU0289739699.SGD","XBI","BK4137","LU0106261372.USD","BK4585","BK4528","VEEV","BK4505","BK4139","LU0006306889.USD","LABU","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662160557","title":"Tvardi Therapeutics to Attend Wells Fargo, Cantor Global Healthcare Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2662160557","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662160557?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:05","pubTimestamp":1787745938,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics to attend Wells Fargo, Cantor global healthcare investor conferencesTvardi Therapeutics management will attend the Wells Fargo 21st Annual Healthcare Conference on Sept. 9, 2026 in","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nNDL6DncBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","LU0314104364.USD","IE00BKPKM429.USD","BK4112","BK4588","LU2210150020.SGD","LU2210149790.SGD","SG9999014005.SGD","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BGHQF748.EUR","BCDF","IE00B64PRP62.GBP","SG9999014039.USD","TVRD","NDAQ","LU2095319765.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662271987","title":"Tvardi Therapeutics to Participate in Upcoming Investor Events","url":"https://stock-news.laohu8.com/highlight/detail?id=2662271987","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662271987?lang=en_us&edition=fundamental","pubTime":"2026-08-26 20:00","pubTimestamp":1787745600,"startTime":"0","endTime":"0","summary":"HOUSTON, Aug.  26, 2026 (GLOBE NEWSWIRE) -- Tvardi Therapeutics, Inc. (“Tvardi”) (NASDAQ: TVRD), a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule th","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/26/3351266/0/en/tvardi-therapeutics-to-participate-in-upcoming-investor-events.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LENZ","BK4007","BK4539","TVRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660764282","title":"Tvardi Therapeutics (TVRD) Receives a Hold from Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2660764282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660764282?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:55","pubTimestamp":1787230551,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst maintained a Hold rating on Tvardi Therapeutics yesterday. The company’s shares closed yesterday at $1.88. Currently, the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-receives-a-hold-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-receives-a-hold-from-cantor-fitzgerald-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TVRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428379","title":"Analysts Are Bullish on These Healthcare Stocks: Tvardi Therapeutics (TVRD), GE Healthcare Technologies Inc (GEHC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428379?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:20","pubTimestamp":1787221227,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tvardi Therapeutics (TVRD), GE Healthcare Technologi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-tvardi-therapeutics-tvrd-ge-healthcare-technologies-inc-gehc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-tvardi-therapeutics-tvrd-ge-healthcare-technologies-inc-gehc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0689626769.HKD","BK4588","BK4082","GEHC","BK4007","TVRD","LGHT","LU0124676726.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404115","title":"Tvardi Therapeutics (TVRD) Gets a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404115","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:55","pubTimestamp":1787212559,"startTime":"0","endTime":"0","summary":"In a report released today, Etzer Darout from Barclays maintained a Sell rating on Tvardi Therapeutics, with a price target of $3.00. According to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-gets-a-sell-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-gets-a-sell-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660217804","title":"Tvardi Therapeutics Posts KOL Webinar Deck on TTI-109 Potential in Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2660217804","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660217804?lang=en_us&edition=fundamental","pubTime":"2026-08-19 23:15","pubTimestamp":1787152507,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics posts KOL webinar deck on TTI-109 potential in ulcerative colitisTvardi Therapeutics posted a medical research presentation outlining the rationale for STAT3 inhibition in ulcerati","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL784lst:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659146675","title":"Tvardi Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2659146675","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659146675?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:47","pubTimestamp":1786708070,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings SummaryTvardi Therapeutics, Inc.TVRD.OQreported a quarterly adjusted loss of 69 cents per share for the quarter ended","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nL8N44B0P2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659143223","title":"Tvardi Q2 FY26 Net Loss Turns to USD 6.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659143223","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659143223?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:01","pubTimestamp":1786705267,"startTime":"0","endTime":"0","summary":"Tvardi Q2 FY26 net loss turns to USD 6.5 millionTvardi Therapeutics posted a Q2 net loss of USD 6.5 million, swinging from net income of USD 4.2 million a year earlier.Loss per share was USD 0.69, ver","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDL2YxHkr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","LU2210150020.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00BN0W2W23.USD","TVRD","BK4007","BCDF","SG9999014021.USD","BK4585","LU2095319765.USD","SG9999014039.USD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659288143","title":"Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659288143","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659288143?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUABJPVQC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414347","title":"Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million VS. Ibes Estimate USD -6.54 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414347?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nPLXSZDCT9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TVRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658972191","title":"Tvardi Therapeutics to Host KOL Webinar on TTI-109 Potential in Ulcerative Colitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2658972191","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658972191?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:08","pubTimestamp":1786536537,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics to host KOL webinar on TTI-109 potential in ulcerative colitisTvardi Therapeutics will host a KOL webinar on Aug. 19, 2026 at 11:00 a.m. ET focused on TTI-109 in ulcerative colitis","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7FwHf8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2V16.EUR","NDAQ","BCDF","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","IE00BKPKM429.USD","TVRD","BK4007","BK4585","SG9999014021.USD","LU2095319765.USD","SG9999014013.SGD","IE00BN0W2W23.USD","LU0314104364.USD","LU2210149790.SGD","BK4112","BK4588","IE00B3QW5Z07.USD","SG9999014005.SGD","SG9999014039.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658372967","title":"Analysts Offer Insights on Healthcare Companies: Spyre Therapeutics (SYRE), Stereotaxis (STXS) and Tvardi Therapeutics (TVRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658372967","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658372967?lang=en_us&edition=fundamental","pubTime":"2026-08-11 14:30","pubTimestamp":1786429817,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Spyre Therapeutics (SYRE), Stereotaxis (STXS) and Tv...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-spyre-therapeutics-syre-stereotaxis-stxs-and-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-spyre-therapeutics-syre-stereotaxis-stxs-and-tvardi-therapeutics-tvrd-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0128526141.USD","STXS","HCSG","LFSC","TVRD","BK4137","BK4585","XBI","BK4588","BK4139","LABU","BK4581","LU0029874061.USD","BK4082","XLV","SYRE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658333309","title":"Tvardi Therapeutics, Inc. Expected to Post a Loss of 70 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2658333309","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658333309?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:23","pubTimestamp":1786360988,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics, Inc. <TVRD.OQ> expected to post a loss of70cents a share - Earnings PreviewTvardi Therapeutics, Inc.TVRD.OQTVRD.Ois expected to  show no change in quarterly revenue when it report","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL8N4470N6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TVRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615033","title":"Tvardi Therapeutics (TVRD) Gets a Sell from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615033","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657615033?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:38","pubTimestamp":1786091889,"startTime":"0","endTime":"0","summary":"In a report released today, Etzer Darout from Barclays maintained a Sell rating on Tvardi Therapeutics, with a price target of $3.00. Darout covers...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-gets-a-sell-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/tvardi-therapeutics-tvrd-gets-a-sell-from-barclays-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TVRD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800840","title":"Analysts’ Top Healthcare Picks: Tvardi Therapeutics (TVRD), Disc Medicine (IRON)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655800840?lang=en_us&edition=fundamental","pubTime":"2026-07-31 02:10","pubTimestamp":1785435008,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Tvardi Therapeutics (TVRD), Disc Medicine (IRON) and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-tvardi-therapeutics-tvrd-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-tvardi-therapeutics-tvrd-disc-medicine-iron-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IRON","XBI","XLV","BK4585","HCSG","BK4588","LABU","BK4581","LU0053671581.USD","TVRD","LU0029874061.USD","BK4137","BK4007","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655241871","title":"Tvardi Therapeutics Plans 2027 Mid-to-late Stage Ulcerative Colitis Trial for STAT3 Inhibitor Tti-109","url":"https://stock-news.laohu8.com/highlight/detail?id=2655241871","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655241871?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:36","pubTimestamp":1785411382,"startTime":"0","endTime":"0","summary":"Tvardi Therapeutics plans 2027 mid-to-late stage ulcerative colitis trial for STAT3 inhibitor TTI-109Tvardi Therapeutics selected ulcerative colitis as the lead indication for its oral STAT3 inhibitor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260730:nNDL2FFK2y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4585","LU2210150020.SGD","LU2095319765.USD","NDAQ","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","SG9999014021.USD","BK4588","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BN0W2W23.USD","LU2210149790.SGD","TVRD","IE00BN0W2V16.EUR","BK4112","SG9999014005.SGD","IE00BGHQF748.EUR","BCDF","IE00BKPKM429.USD","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652802482","title":"Tvardi Therapeutics - Increases At-the-market Offering Program to $9.69 Mln in Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2652802482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652802482?lang=en_us&edition=fundamental","pubTime":"2026-07-18 04:12","pubTimestamp":1784319143,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43J0TC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","TVRD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":61,"code":"91000000","status":"200"}]}}